Tech Edge hosted a fireside chat on April 29 at RSAC 2025 in San Francisco with Doug Murray, Chief Executive Officer at Auvik. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the specific industry challenges that...

Tech Edge hosted a fireside chat on April 29 at RSAC 2025 in San Francisco with Omer Itzhak, Vice President of Product at Cytactic. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the specific pain points in...

Tech Edge hosted a fireside chat on April 30 at RSAC 2025 in San Francisco with Dan Amiga, co-founder and Chief Technology Officer at Island. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the enterprise browser market...

Tech Edge hosted a fireside chat on April 29 at RSAC 2025 in San Francisco with Corey Still, Vice President of Strategic Alliances at Corero Network Security. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed which...

By Daniella Parra Vinson & Elkins represented Sunoco LP (NYSE: SUN) in a definitive agreement with Parkland Corp. (TSX: PKI) where Sunoco will acquire all outstanding shares of Parkland in a cash and equity transaction valued at approximately $9.1 billion,...

Tech Edge hosted a fireside chat on April 30 at Sysdig headquarters in San Francisco with Karen Walker, Chief Financial Officer. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the market trends driving increased investment in...

Tech Edge hosted a fireside chat on April 29 at RSAC 2025 in San Francisco with Seth Spergel, Managing Partner at Merlin Ventures. The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed why Merlin Ventures has focused...

By Karen Roman Recordati said it established its three-year financial targets for 2025-2027, with expected revenue of €3.0 to €3.2 billion for 2027 and EBITDA of €1.14 to €1.225 billion. The company’s strategy is driven by organic growth, its leadership,...

By Daniella Parra Araris Biotech AG  joined a research agreement with Johnson & Johnson’s Janssen Biotech to advance the development of next-generation antibody-drug conjugates (ADCs), they said. The partnership will leverage Araris’ proprietary AraLinQ technology, a one-step, enzymatic conjugation platform...

By Karen Roman ReAlta Life Sciences said it is presenting new data from its hypoxic ischemic encephalopathy (HIE) program at the Pediatric Academic Societies Annual Meeting, taking place in Honolulu, Hawaii, from April 24-28, 2025. The findings confirm elevated inflammatory...